Jan 10, 2023 / 10:15PM GMT
Unidentified Analyst -
Hey, everyone. How's it going? My name is (inaudible). I cover medical devices and supplies here at JPMorgan. I'd just like to introduce Chris Simon, CEO of Haemonetics.
Christopher A. Simon - Haemonetics Corporation - CEO, President & Director
Thanks, (inaudible). Good afternoon and welcome. We're obviously very pleased to be back at JPMorgan, especially here in person after the time away. So I'm excited to provide you a look at where Haemonetics is today, where we are headed, including some unique opportunities that will enable an even greater impact across the markets we serve and help us deliver significant value, both for customers and ultimately for shareholders.
My remarks here today will have forward-looking non-GAAP numbers involved. So typical risk factors apply. You can refer to our SEC filings for any more information or questions you may have.
Back in June, we shared our updated long-range plan for transformational growth. Strong performance this year to date is evidence that our plan is working, and we are
Haemonetics Corp at JPMorgan Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers